Trials / Completed
CompletedNCT03510676
The ILLUMINA Study. (ILLUMINA)
Innovative siroLimus seLf Expanding drUg-eluting Stent for the treatMent of perIpheral Disease: Evaluation of Safety aNd efficAcy. The ILLUMINA Study. (ILLUMINA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- CID - Carbostent & Implantable Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the prospective, multicentre, single-arm study is to assess safety and efficacy of a drug eluting stent in Nitinol alloy (NiTiDES) in term of vessel patency and composite event-free survival rate up to two years follow-up in focal/medium length lesions in patients with ischemic obstruction of superficial femoral arteries or/and proximal popliteal arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | NiTiDES |
Timeline
- Start date
- 2016-01-26
- Primary completion
- 2018-03-07
- Completion
- 2019-03-07
- First posted
- 2018-04-27
- Last updated
- 2021-07-13
Locations
10 sites across 3 countries: France, Germany, Italy
Source: ClinicalTrials.gov record NCT03510676. Inclusion in this directory is not an endorsement.